
GLAXOSMITHKLINE PLC
GSK
![]() |
|
1348.4GBX | +4.56% |
Turn to zoom
Prev. | 1289.6000 |
Open | 1285.6000 |
High | 1388.4000 |
Low | 1269.0890 |
Volume | 21 234 212 |
Latest news
Chart GLAXOSMITHKLINE PLC
Technical analysis trends
Short Term | Mid-Term | Long Term | |
Trend | Bullish | Neutral | Bearish |
Resistance | 1 367 | 1 468 | 1 414 |
Spread/Res. | -1,4% | -8,1% | -4,6% |
Spread/Supp. | 5,5% | 13% | 13% |
Support | 1 278 | 1 191 | 1 191 |
Financials
|
|
Company
GlaxoSmithkline plc is the world's No. 2 pharmaceutical group. Net sales break down by family of products as follows:
- pharmaceutical products (50%): intended for respiratory diseases (64.9% of net sales), HIV infection (28.6%), immune system disorders (4.3%) ) and cancer (2.2%);
- OTC and...
>> Read more
- pharmaceutical products (50%): intended for respiratory diseases (64.9% of net sales), HIV infection (28.6%), immune system disorders (4.3%) ) and cancer (2.2%);
- OTC and...
>> Read more
Sector : |
Other Pharmaceuticals
|
Calendar : |
2021-04-28 Earnings Release
|
Trading Rating : |
Investor Rating : |
Income Statement Evolution
Consensus
Mean consensus | HOLD |
Number of Analysts | 27 |
Average target price | 1 516,25 GBX |
Last Close Price | 1 348,40 GBX |
Spread / Highest target | 52,0% |
Spread / Average Target | 12,4% |
Spread / Lowest Target | -28,5% |